Ma Kuang Healthcare Holding Limited

As of June 30, 2026, Ma Kuang Healthcare Holding Limited carries a market capitalization of 1.11B, placing it among publicly traded companies globally. Its enterprise value stands at 1.73B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Ma Kuang Healthcare Holding Limited has 45.01M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 1.00, and the price-to-book ratio stands at 2.70.

As of June 30, 2026, Ma Kuang Healthcare Holding Limited trades at an EV/EBITDA multiple of 10.96 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.60 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 1.73B versus a market cap of 1.11B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Ma Kuang Healthcare Holding Limited maintains a current ratio of 0.62, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 153.23, indicating elevated leverage, while an interest coverage ratio of 4.57 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Ma Kuang Healthcare Holding Limited posted a negative return on equity (ROE) of -24.05, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -7.64, reflecting losses generated across the asset base. The company generates approximately 2.01M in revenue per employee across its workforce of 540.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 24.52 indicates how many times Ma Kuang Healthcare Holding Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Ma Kuang Healthcare Holding Limited recorded 10.78M in income tax expense. The company reported a pretax loss of -107.37M and -101.82M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 21, 2026, Ma Kuang Healthcare Holding Limited's stock has gained approximately 75.25% over the past 52 weeks. The 50-day moving average sits at 40.61, while the 200-day moving average is 29.58.

Over the twelve months ended June 30, 2026, Ma Kuang Healthcare Holding Limited generated 1.09B in revenue and converted that into -101.82M in net income, yielding earnings per share of -2.67. EBITDA reached 158.15M, while operating income came in at -25.80M.

As of June 30, 2026, Ma Kuang Healthcare Holding Limited holds 71.22M in cash and equivalents against 670.72M in total debt, resulting in a net debt position of 332.22M. Total book value stands at 410.54M, with working capital of -193.46M providing operational flexibility.

Ma Kuang Healthcare Holding Limited produced 183.80M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -24.55M in capital expenditures, free cash flow totaled 159.25M - equivalent to 3.60 per share.

Over the twelve months ended June 30, 2026, Ma Kuang Healthcare Holding Limited posted a gross margin of 11.11, reflecting its pricing power and cost economics. The operating margin of -2.38 and net profit margin of -9.38 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 14.64, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 21.20, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Ma Kuang Healthcare Holding Limited shareholders.

Ma Kuang Healthcare Holding Limited's most recent stock split took place on July 16, 2020 with a 500:507 split ratio.

As of June 30, 2026, Ma Kuang Healthcare Holding Limited has an Altman Z-Score of 1.29, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.